CI Strangle Strategy
CI (Cigna Corporation), in the Healthcare sector, (Medical - Healthcare Plans industry), listed on NYSE.
The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
CI (Cigna Corporation) trades in the Healthcare sector, specifically Medical - Healthcare Plans, with a market capitalization of approximately $79.55B, a trailing P/E of 12.56, a beta of 0.31 versus the broader market, a 52-week range of 239.51-338.89, average daily share volume of 1.8M, a public-listing history dating back to 1982, approximately 71K full-time employees. These structural characteristics shape how CI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.31 indicates CI has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. CI pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on CI?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current CI snapshot
As of May 15, 2026, spot at $286.23, ATM IV 27.87%, IV rank 27.17%, expected move 7.99%. The strangle on CI below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this strangle structure on CI specifically: CI IV at 27.87% is on the cheap side of its 1-year range, which favors premium-buying structures like a CI strangle, with a market-implied 1-standard-deviation move of approximately 7.99% (roughly $22.87 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CI expiries trade a higher absolute premium for lower per-day decay. Position sizing on CI should anchor to the underlying notional of $286.23 per share and to the trader's directional view on CI stock.
CI strangle setup
The CI strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CI near $286.23, the first option leg uses a $300.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CI chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CI shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $300.00 | $3.30 |
| Buy 1 | Put | $270.00 | $2.93 |
CI strangle risk and reward
- Net Premium / Debit
- -$622.50
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$622.50
- Breakeven(s)
- $263.78, $306.23
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
CI strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on CI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$26,376.50 |
| $63.30 | -77.9% | +$20,047.91 |
| $126.58 | -55.8% | +$13,719.31 |
| $189.87 | -33.7% | +$7,390.72 |
| $253.15 | -11.6% | +$1,062.13 |
| $316.44 | +10.6% | +$1,021.46 |
| $379.73 | +32.7% | +$7,350.06 |
| $443.01 | +54.8% | +$13,678.65 |
| $506.30 | +76.9% | +$20,007.24 |
| $569.58 | +99.0% | +$26,335.84 |
When traders use strangle on CI
Strangles on CI are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CI chain.
CI thesis for this strangle
The market-implied 1-standard-deviation range for CI extends from approximately $263.36 on the downside to $309.10 on the upside. A CI long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current CI IV rank near 27.17% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CI at 27.87%. As a Healthcare name, CI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CI-specific events.
CI strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CI positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CI alongside the broader basket even when CI-specific fundamentals are unchanged. Always rebuild the position from current CI chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on CI?
- A strangle on CI is the strangle strategy applied to CI (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With CI stock trading near $286.23, the strikes shown on this page are snapped to the nearest listed CI chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CI strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CI strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 27.87%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$622.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CI strangle?
- The breakeven for the CI strangle priced on this page is roughly $263.78 and $306.23 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CI market-implied 1-standard-deviation expected move is approximately 7.99%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on CI?
- Strangles on CI are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CI chain.
- How does current CI implied volatility affect this strangle?
- CI ATM IV is at 27.87% with IV rank near 27.17%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.